PRA Health Sciences’ Early Development Services (EDS) group has a long-standing record of early clinical development work in various neuroscience and pain indication. In the past decade, PRA EDS in the Netherlands has gained extensive experience in neuroactive drug development through 160+ Phase I and Phase II clinical studies. PRA’s US clinical research centers offer addition expertise in neuroscience and pain early phase trials.
Lenexa Kansas - Clinical Pharmacology Center
PRA Health Sciences offer a full-suite of global, clinical pharmacology services. Our Lenexa, Kansas, clinic is co-located with our bioanalytical…
Targeting Patients In A Complex Phase II Rheumatoid Arthritis Study
Targeting Patients In A Complex Phase IIa Rheumatoid Arthritis Study.
ECG Assessments During the Development of Oncology Compounds
Single-center oncology studies performed by dedicated PRA staff, combined with the High Precision QT approach of iCardiac, generates conclusive ECG…